Home
Scholarly Works
Correction: Transitioning subcutaneous...
Journal article

Correction: Transitioning subcutaneous immunoglobulin 20% therapies in patients with primary and secondary immunodeficiencies: Canadian real‑world study

Authors

Keith PK; Cowan J; Kanani A; Kim H; Lacuesta G; Lee JK; Chen J; Park M; Gladiator A

Journal

Allergy, Asthma & Clinical Immunology, Vol. 19, No. 1,

Publisher

Springer Nature

Publication Date

December 1, 2023

DOI

10.1186/s13223-023-00805-3

ISSN

1710-1484

Contact the Experts team